IMMUNOHISTOCHEMICAL ASSESSMENT OF PROLIFERATION AND APOPTOSIS OF KERATINOCYTES AFTER A SINGLE FRACTIONAL IONIZING IRRADIATION

Radiation therapy for non-melanoma skin cancers is used by oncologists and radiologists in cases of ineffective surgical treatment and as adjuvant or palliative therapy. The creation of experimental models to study the proliferative-apoptotic balance of keratinocytes makes it possible to assess the degree and depth of post-radiation skin damage after exposure to electrons in order to select optimal doses in the clinic. The purpose of the study: immunohistochemical assessment of proliferation and apoptosis of keratinocytes after local electron irradiation of the skin. The experiment used male Wistar rats (n=50), which were divided into groups: I – control (n=20), which were injected with saline solution, and experimental rats, which received local electron irradiation of the skin of the outer surface of the thigh: II – 8 Gy (n=10; single), III – 40 Gy (n=10, single), IV – fractional 13 Gy for 6 days with a total focal dose of 78 Gy (n=10;). After completion of the experiment, a skin biopsy of the outer surface of the thigh was performed and an immunohistochemical study of histological preparations with antibodies to the Ki-67, caspase-3 and p53 antigens was performed. Analysis of skin fragments after irradiation showed a shift in the proliferative-apoptotic balance towards keratinocyte apoptosis: a decrease in the level of Ki-67 expression and an increase in the number of p53-positive cells. After a single irradiation with electrons at doses of 8 Gy and 40 Gy, a significant increase in keratinocytes stained positively with antibodies to caspase-3 was found - by 3.4 and 6.6 times, respectively, and with a fractional irradiation mode at a total dose of 78 Gy - by 11.6 times compared to the control group. Thus, local irradiation with electrons in single doses of 8 Gy and 40 Gy leads to a shift in the proliferative-apoptotic balance of keratinocytes towards their apoptosis, the activity of which is directly proportional to the dose of ionizing radiation, and the fractional mode (total focal dose of 78 Gy) leads to partial desquamation of the epithelium and inflammatory infiltration.

1. Perez M, Abisaad JA, Rojas KD, et al. Skin cancer: Primary, secondary, and tertiary prevention. Part I. J Am Acad Dermatol. 2022;87(2):255-268. DOI:10.1016/j.jaad.2021.12.066

2. Cives M, Mannavola F, Lospalluti L, et al. Non-Melanoma Skin Cancers: Biological and Clinical Features. Int J Mol Sci. 2020;21(15):5394. DOI:10.3390/ijms21155394

3. Pashazadeh A, Boese A, Friebe M. Radiation therapy techniques in the treatment of skin cancer: an overview of the current status and outlook. J Dermatolog Treat. 2019;30(8):831-839. DOI:10.1080/09546634.2019.1573310

4. Chua B, Jackson JE, Lin C, Veness MJ. Radiotherapy for early non-melanoma skin cancer. Oral Oncol. 2019;98:96-101. DOI:10.1016/j.oraloncology.2019.09.018

5. Locke J, Karimpour S, Young G, et al. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):748-755. DOI:10.1016/s0360-3016(01)01656-x

6. Olschewski T, Bajor K, Lang B, et al. Radiotherapie des Basalzellkarzinoms im Gesichts-/Kopfbereich: Bedeutung einer niedrigen Einzeldosis für das Langzeitsergebnis [Radiotherapy of basal cell carcinoma of the face and head: Importance of low dose per fraction on long-term outcome]. J Dtsch Dermatol Ges. 2006;4(2):124-130. DOI:10.1111/j.1610-0387.2006.05880.x

7. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071-1078. DOI:10.1038/nature08467

8. Mehta SR, Suhag V, Semwal M, Sharma N. Radiotherapy: Basic Concepts and Recent Advances. Med J Armed Forces India. 2010;66(2):158-162. DOI:10.1016/S0377-1237(10)80132-7

9. Yoshimura M, Itasaka S, Harada H, Hiraoka M. Microenvironment and radiation therapy. Biomed Res Int. 2013;2013:685308. DOI:10.1155/2013/685308

10. Lumniczky K, Sáfrány G. The impact of radiation therapy on the antitumor immunity: local effects and systemic consequences. Cancer Lett. 2015;356(1):114-125. DOI:10.1016/j.canlet.2013.08.024

11. Brix N, Tiefenthaller A, Anders H, et al. Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences. Immunol Rev. 2017;280(1):249-279. DOI:10.1111/imr.12573

12. Jeong H, Bok S, Hong BJ, et al. Radiation-induced immune responses: mechanisms and therapeutic perspectives. Blood Res. 2016;51(3):157-163. DOI:10.5045/br.2016.51.3.157

13. Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10(7):718-726. DOI:10.1016/S1470-2045(09)70082-8

14. van Hezewijk M, Creutzberg CL, Putter H, et al. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases. Radiother Oncol. 2010;95(2):245-249. DOI:10.1016/j.radonc.2010.02.024

15. Guo M, Hay BA. Cell proliferation and apoptosis. Curr Opin Cell Biol. 1999;11(6):745-752. DOI:10.1016/s0955-0674(99)00046-0

16. Ward WF, Molteni A, Ts'ao C, Hinz JM. The effect of Captopril on benign and malignant reactions in irradiated rat skin. Br J Radiol. 1990;63(749):349-354. DOI:10.1259/0007-1285-63-749-349

17. Ran X, Cheng T, Shi C, Xu H, et al. The effects of total-body irradiation on the survival and skin wound healing of rats with combined radiation-wound injury. J Trauma. 2004;57(5):1087-1093. DOI:10.1097/01.ta.0000141885.72033.c7

18. Li Z, Gan H, Liang A, Wang X, et al. Promoting repair of highly purified stromal vascular fraction gel combined with advanced platelet-rich fibrin extract for irradiated skin and soft tissue injury. Ann Transl Med. 2022;10(17):933. DOI:10.21037/atm-22-3956

19. McPartlin AJ, Slevin NJ, Sykes AJ, Rembielak A. Radiotherapy treatment of non-melanoma skin cancer: a survey of current UK practice and commentary. Br J Radiol. 2014;87(1043):20140501. DOI:10.1259/bjr.20140501

20. Wang XJ, Lin S, Kang HF, et al. The effect of RHIZOMA COPTIDIS and COPTIS CHINENSIS aqueous extract on radiation-induced skin injury in a rat model. BMC Complement Altern Med. 2013;13:105. DOI:10.1186/1472-6882-13-105

21. Wang Q, Zhou Y, Wang X, Evers BM. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Oncogene. 2006;25(1):43-50. DOI:10.1038/sj.onc.1209004

22. Morel C, Carlson SM, White FM, Davis RJ. Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol Cell Biol. 2009;29(14):3845-3852. DOI:10.1128/MCB.00279-09

23. Reisz JA, Bansal N, Qian J, et al. Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection. Antioxid Redox Signal. 2014;21(2):260-292. DOI:10.1089/ars.2013.5489

24. Khavkin J, Ellis DA. Aging skin: histology, physiology, and pathology. Facial Plast Surg Clin North Am. 2011;19(2):229-234. DOI:10.1016/j.fsc.2011.04.003

25. Martincorena I, Roshan A, Gerstung M, et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348(6237):880-886. DOI:10.1126/science.aaa6806